BNP Paribas Asset Management
AVNS

BNP Paribas Asset Management’s Avanos Medical AVNS Stock Holding History

BNP Paribas Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.9K Sell
1,281
-384
-23% -$8.99K ﹤0.01% 1926
2026
Q1 		$23.3K Buy
1,665
+490
+42% +$6.6K ﹤0.01% 1983
2025
Q4 		$13K Buy
1,175
+308
+36% +$3.52K ﹤0.01% 2066
2025
Q3 		$10K Buy
867
+250
+41% +$2.93K ﹤0.01% 1620
2025
Q2 		$8K Buy
+617
New +$7.76K ﹤0.01% 1835

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BNP Paribas Asset Management's AVNS Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Avanos Medical (AVNS) stake by 23% in Q2 2026, selling an estimated $8.99K and leaving 1,281 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1926.

BNP Paribas Asset Management first reported a position in AVNS in Q2 2025 and has held it in 5 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • BNP Paribas Asset Management held 1,281 shares of Avanos Medical worth $31.9K as of Q2 2026.
  • BNP Paribas Asset Management sold 384 Avanos Medical shares in Q2 2026, an estimated $8.99K.
  • Avanos Medical made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1926 holding.
  • BNP Paribas Asset Management first reported a position in Avanos Medical in Q2 2025 and has held it in 5 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.